News Detail
New Delhi, 2 Jan 2025: The Central Drugs Standard Control Organization (CDSCO) plans to further tighten the screws this year on those making and selling spurious and substandard medicines, a widespread problem in India.
As part of the plan, in addition to t......
View Details
Source : Livemint
CDSCO
drug safety
quality
GMP
good manufacturing practices
Schedule M
Union territories
RBI
MSME
Drugs and Cosmetics Act
Spurious drug
investigation
Not of standard quality
Related News
- Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)
- Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)
- SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)
- 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)